Orange Book product · Generic (ANDA)
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
At a glance
Mar 07, 2014
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 07, 2014
12 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Strength
12.5MG;7.5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 202150
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
- 1997UNIRETICBrand (NDA)
NDA 020729 · UCB INC
- 2010MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090718 · GLENMARK PHARMS
- 2008MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090096 · CHARTWELL RX
- 2007MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 076980 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
